Cat: IPD-X10877

Recombinant Mouse IL-9R Protein , N-His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    IL-9R

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    CD129; IL9-R; Cluster Of Differentiation 129

  • 种属

    Mouse

  • 表达系统

    E. coli

  • 标签

    N-His

  • 纯度

    > 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q01114

  • 表达区间

    Val38~Ser270

  • 分子量

    30kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Interleukin-9 receptor (IL-9R) is a critical component of the immune system, primarily associated with the signaling pathways of interleukin-9 (IL-9), a cytokine that plays a significant role in various allergic and inflammatory responses. Research into IL-9R has gained momentum due to its involvement in the pathogenesis of several diseases, including asthma, allergic rhinitis, and certain types of cancer. The IL-9/IL-9R axis is known to influence T-helper cell differentiation, particularly promoting the survival and proliferation of mast cells and enhancing the production of other pro-inflammatory cytokines. This makes IL-9R a potential therapeutic target for modulating immune responses and developing new treatment strategies for allergic diseases and malignancies. The generation of recombinant IL-9R proteins is essential for studying its biological functions, understanding receptor interactions, and screening potential inhibitors or antagonists. Recent advances in recombinant protein technology have enabled the production of high-quality IL-9R for use in various assays, paving the way for deeper insights into its signaling mechanisms and potential clinical applications. Additionally, investigating the structural aspects of IL-9R through crystallography and molecular modeling has provided valuable information that could guide drug design efforts. As research continues, the characterization of IL-9R and its signaling pathways will further clarify its role in immune regulation and disease, highlighting the importance of this receptor in both basic and applied biomedical sciences.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US